Matthew A Allison1, C Michael Wright. 1. University of California at San Diego, 8950 Villa La Jolla Drive, Suite C203, La Jolla, CA 92037, USA. mallison@ucsd.net
Abstract
BACKGROUND: Coronary calcification is a marker for coronary atherosclerosis. It has been postulated that high levels of high density lipoprotein cholesterol (HDL-C) are associated with a reduced amount of atherosclerotic disease while previous reports have found a lack of association between low density lipoprotein cholesterol (LDL-C) and coronary calcification (CAC). The purpose of this study was to compare the correlation and predictive power of HDL-C with LDL-C for prevalent coronary calcification. METHODS: A total of 6093 subjects were studied with respect to coronary calcification, serum cholesterol indices, personal health history and body morphology. Analyses consisted of correlation coefficients, logistic regression and sensitivity analysis to determine the strength of association between HDL-C and coronary calcification after controlling for covariates. RESULTS: The correlation between HDL-C and coronary calcium score (CCS) was three times that of LDL-C. Individuals with an HDL-C level <40 mg/dl had significantly higher calcium scores while increases in HDL-C were associated with a significant reduction in risk for the presence of any calcified plaque. Results of multivariate logistic regression revealed that HDL-C is predictive of calcified plaque development independent of LDL-C. Sensitivities and positive predictive values for both HDL-C and LDL-C were low. CONCLUSIONS: Increasing levels of HDL-C were associated with less coronary calcification and a smaller probability of having any calcified disease supporting the antiatherogenic hypothesis for HDL-C. HDL-C predicts the presence of any calcified atherosclerotic plaque independently of LDL-C. However, neither parameter seems suitable as a screening tool for predicting prevalent calcified atheromatous disease.
BACKGROUND:Coronary calcification is a marker for coronary atherosclerosis. It has been postulated that high levels of high density lipoprotein cholesterol (HDL-C) are associated with a reduced amount of atherosclerotic disease while previous reports have found a lack of association between low density lipoprotein cholesterol (LDL-C) and coronary calcification (CAC). The purpose of this study was to compare the correlation and predictive power of HDL-C with LDL-C for prevalent coronary calcification. METHODS: A total of 6093 subjects were studied with respect to coronary calcification, serum cholesterol indices, personal health history and body morphology. Analyses consisted of correlation coefficients, logistic regression and sensitivity analysis to determine the strength of association between HDL-C and coronary calcification after controlling for covariates. RESULTS: The correlation between HDL-C and coronary calcium score (CCS) was three times that of LDL-C. Individuals with an HDL-C level <40 mg/dl had significantly higher calcium scores while increases in HDL-C were associated with a significant reduction in risk for the presence of any calcified plaque. Results of multivariate logistic regression revealed that HDL-C is predictive of calcified plaque development independent of LDL-C. Sensitivities and positive predictive values for both HDL-C and LDL-C were low. CONCLUSIONS: Increasing levels of HDL-C were associated with less coronary calcification and a smaller probability of having any calcified disease supporting the antiatherogenic hypothesis for HDL-C. HDL-C predicts the presence of any calcified atherosclerotic plaque independently of LDL-C. However, neither parameter seems suitable as a screening tool for predicting prevalent calcified atheromatous disease.
Authors: Lynne E Wagenknecht; Carl D Langefeld; Barry I Freedman; J Jeffery Carr; Donald W Bowden Journal: Am J Epidemiol Date: 2007-05-09 Impact factor: 4.897
Authors: Evadnie Rampersaud; Lawrence F Bielak; Afshin Parsa; Haiqing Shen; Wendy Post; Kathleen A Ryan; Patrick Donnelly; John A Rumberger; Patrick F Sheedy; Patricia A Peyser; Alan R Shuldiner; Braxton D Mitchell Journal: Am J Epidemiol Date: 2008-09-19 Impact factor: 4.897
Authors: Connie W Tsao; Sarah Rosner Preis; Gina M Peloso; Shih-Jen Hwang; Sekar Kathiresan; Caroline S Fox; L Adrienne Cupples; Udo Hoffmann; Christopher J O'Donnell Journal: J Am Coll Cardiol Date: 2012-11-07 Impact factor: 24.094
Authors: Erin D Michos; Dhananjay Vaidya; Susan M Gapstur; Pamela J Schreiner; Sherita H Golden; Nathan D Wong; Michael H Criqui; Pamela Ouyang Journal: Atherosclerosis Date: 2008-02-08 Impact factor: 5.162
Authors: Ji Sun Nam; Min Kyung Kim; Joo Young Nam; Kahui Park; Shinae Kang; Chul Woo Ahn; Jong Suk Park Journal: Lipids Health Dis Date: 2020-07-02 Impact factor: 3.876
Authors: Ana Paula Santana Gueiros; José Edevanilson de Barros Gueiros; Karina Tavares Nóbrega; Eveline Barros Calado; Marina Cadena da Matta; Leuridan Cavalcante Torres; Alex Sandro Rolland Souza; Dulce Elena Casarini; Aluizio Barbosa de Carvalho Journal: J Bras Nefrol Date: 2019-08-15